Seelos Therapeutics, Inc.
Pharmaceutical company · New York, United States
Seelos Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $3.7 million sold in a notice filed in 2017.
Profile compiled from public records. Is this your company? Request a correction or update
Seelos Therapeutics at a glance
Typepharmaceutical company
HeadquartersNew York, United States
SEC industryPharmaceutical Preparations
SEC CIK1017491
What does Seelos Therapeutics do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $3.7 million sold (2017).
Frequently asked questions about Seelos Therapeutics
Where is Seelos Therapeutics headquartered?
Seelos Therapeutics, Inc. is headquartered in New York, United States.
What does Seelos Therapeutics do?
Seelos Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences